Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasticell
Stevenage, Hertfordshire, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Plasticell is advancing pre-clinical programs in allogeneic cancer immunotherapy, hematopoietic stem cell expansion, and regenerative therapies. It has demonstrated proprietary combinatorial screening for discovering optimal stem cell differentiation and expansion protocols, and has ongoing collaborations to industrialize allogeneic iPSC-derived NK cell therapy manufacturing.[1][2][5]
- Therapeutic areas
- EndocrinologyRheumatologyNeurologyRare DiseasesHematologyOncology
- Modalities
- Small moleculeCell therapyGene therapyInduced pluripotent stem cell derived therapyAllogeneic cell therapy
- Industry
- Biotech
02
Partnerships
GSKEMD MilliporeSigma-AldrichCell and Gene Therapy CatapultImperial College London
Beyond the preview
Go deeper on Plasticell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Plasticell.